Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Peering into the body and visualizing its molecular secrets one step closer to reality

Peering into the body and visualizing its molecular secrets one step closer to reality

Decoding gene expression in cancer tumors using noninvasive imaging

Decoding gene expression in cancer tumors using noninvasive imaging

Cure for hepatitis C

Cure for hepatitis C

Hepatitis C infection is associated with an increased risk of non-Hodgkin lymphoma

Hepatitis C infection is associated with an increased risk of non-Hodgkin lymphoma

Hepatitis C increases risk for non-Hodgkin's lymphoma

Hepatitis C increases risk for non-Hodgkin's lymphoma

Moderate coffee drinking reduces many risks

Moderate coffee drinking reduces many risks

Cellular protein found that interferes with hepatitis C virus replication

Cellular protein found that interferes with hepatitis C virus replication

New test for liver disease

New test for liver disease

Developing world can expect a 'pandemic of cancer' by 2020

Developing world can expect a 'pandemic of cancer' by 2020

North Shore-LIJ seeks participants for liver tumor and new chemo trial

North Shore-LIJ seeks participants for liver tumor and new chemo trial

Scientists isolate enzyme that could be used to predict survival for nasopharyngeal cancer

Scientists isolate enzyme that could be used to predict survival for nasopharyngeal cancer

Progen Pharmaceuticals announces positive results in PI-88 trial

Progen Pharmaceuticals announces positive results in PI-88 trial

Potential biomarkers for early detection of liver cancer

Potential biomarkers for early detection of liver cancer

New drug therapy zaps hepatitis C in 12 weeks

New drug therapy zaps hepatitis C in 12 weeks

Use of computer-assisted drug design in drug discovery

Use of computer-assisted drug design in drug discovery

Recognition for cancer researchers

Recognition for cancer researchers

Blueprint for cell, tissue and organ donation and transplantation

Blueprint for cell, tissue and organ donation and transplantation

Hepatitis A and Hepatitis B cases at lowest levels ever reported

Hepatitis A and Hepatitis B cases at lowest levels ever reported

Mayo Clinic tests engineered measles virus against multiple myeloma

Mayo Clinic tests engineered measles virus against multiple myeloma

The model for end-stage liver disease

The model for end-stage liver disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.